摘要
目的 探讨早期联合应用经鼻持续气道正压通气（NCPAP）和肺表面活性物质（PS）治疗新生儿呼吸窘迫综合征的临床效果。方法 选取本院2012年12月-2014年12月收治的60例新生儿呼吸窘迫综合征患儿作为研究对象,随机分为观察组和对照组,各30例。对照组给予经鼻持续气道正压通气,观察组给予经鼻持续气道正压通气和肺表面活性物质联合应用。比较两组用药后不同时间的p H值、动脉血氧分压、二氧化碳分压改变情况。结果 观察组用药1、12、24 h的p H值显著大于对照组同时间段,差异有统计学意义（P〈0.05）。观察组用药1、12、24 h的动脉血氧分压显著高于对照组同时间段,差异有统计学意义（P〈0.05）。观察组用药1、12、24 h的动脉血二氧化碳分压低于对照组同时间段,差异有统计学意义（P〈0.05）。结论 早期联合应用NCPAP和PS治疗新生儿呼吸窘迫综合征临床效果显著,值得临床推广应用。
Objective To explore the clinical effect of the early combined application of nasal continuous positive air- way pressure （NCPAP） and pulmonary surfactant （PS） in the treatment of neonatal respiratory distress syndrome. Meth- ods 60 cases with neonatal respiratory distress syndrome from December 2012 to December 2014 in our hospital were selected and randomly divided into the observation group and the control group,30 cases in each group.The control group was treated with nasal continuous positive airway pressure,the observation group was treated with the combined application of nasal continuous positive airway pressure and pulmonary surfactant.The changes of pH value,arterial par- tial pressure of oxygen and carbon dioxide partial pressure was compared in the two groups after treatment at different time. Results The pH value after treatment at 1,12 and 24 h in the observation group was larger than that in the con- trol group at the same time,with significant difference （P〈0.05）.The arterial partial pressure of oxygen after treatment at 1,12 and 24 h in the observation group was higher than that in the control group at the same time,with significant dif- ference （P〈0.05）.The arterial partial pressure of carbon dioxide after treatment at 1,12 and 24 h in the observation group was higher than that in the control group at the same time,with significant difference （P〈0.05）. Conclusion Early application of NCPAP and PS in the treatment of neonatal respiratory distress syndrome has significant effect,it is wor- thy of clinical promotion and application.
出处
《中国当代医药》
2016年第13期101-103,共3页
China Modern Medicine
关键词
新生儿呼吸窘迫综合征
经鼻持续气道正压通气
肺表面活性物质
Neonatal respiratory distress syndrome
Nasal continuous positive airway pressure
Pulmonary surfactant
